• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Sanofi Releases the Pre-quarterly Results Communication

    Gabrielle Lakusta
    Jan. 24, 2018 08:36AM PST
    Pharmaceutical Investing

    Sanofi (NYSE:SNY) announced today that its Pre-Quarterly Results Communication document is available on the “Investors” page of the company’s corporate website. As quoted in the press release: As for each quarter, Sanofi prepared this document to assist in the financial modeling of the Group’s quarterly results. This document includes a reminder on various non-comparable items and …

    Sanofi (NYSE:SNY) announced today that its Pre-Quarterly Results Communication document is available on the “Investors” page of the company’s corporate website.
    As quoted in the press release:

    As for each quarter, Sanofi prepared this document to assist in the financial modeling of the Group’s quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count. Sanofi’s fourth quarter results will be published on February 7, 2018.

    Click here to read the full update.

    pharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered

    Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance

    Pfizer Declares Second-Quarter 2023 Dividend

    Pfizer Declares Second-Quarter 2023 Dividend

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Cardiol Therapeutics

    CRDL:CA

    Invion Limited

    IVX:AU

    Principal Technologies

    PTEC:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×